Toggle Nav
Search
Advanced Search
My Cart
  • Compare Products

BalanCD HEK293

In stock
Catalog ID
91165, 94137

Optimized for transient gene expression, and production of viral vectors and recombinant proteins.

main product photo
Size Stock SKU Unit Price Qty
1 L - Liquid In Stock 91165-1L
$144.00
    10 L - Powder In Stock 94137-10L
    $600.00
      10 L - Bag In Stock 91165-10L
      $1,767.00
        20 L - Bag In Stock 91165-20L
        $2,380.00
          reset
          Request More Info
          Request A Quote
          Shipping Info
          Details

          BalanCD HEK293 medium is a versatile, chemically-defined, animal component-free medium optimized for transfection and production of viral vectors and recombinant proteins.

          One medium supports multiple applications including:

          • Rapid, scalable production of viral vectors for gene therapy (adeno-associated viruses (AAV), lentiviruses)
          • Transient protein expression and recombinant protein production to gram-scale yields

          Formulated for versatility and ease-of-use:

          • Streamline workflows with one medium for growth, seeding, transfection, and production
          • Versatile and scalable protocol for use in flasks, spinner flasks, and bioreactors
          • Maximize growth and titer by adding complementary BalanCD HEK293 Feed and/or Anti-Clumping Supplement

          Fulfills regulatory requirements:

          • Chemically-defined, animal-component free
          • Drug Master File (DMF) filed with US FDA

          Figure 1. Simple, scalable protocol supports cell growth and increases yield of lentiviral vector

          Figure 2. Increase protein yield compared to other commercially-available media

          Specifications

          Storage
          Store at 2-8°C and protect from light.
          Shelf Life
          1 year from date of manufacture for 91165 (Liquid)
          2 years from date of manufacture for 94137 (Powder)

          Related Items

          Product Inserts
          BalanCD HEK293 Media System
          Product Sheets
          BalanCD HEK293 System
          Brochures
          Transforming Media Preparation: Oceo Rover and BalanCD Media
          FAQs
          HEK293 System FAQ
          General Bioproduction Products FAQ
          Bioproduction Serum-Free Products FAQ
          Workflows
          CAR-T Cell Therapy Workflow
          Viral Vector Production Workflow (Fed-batch Process)
          Scientific Posters
          A Versatile and Scalable Media Platform Designed for Cell Based Applications Using Human Embryo
          Adaptation of Adherent HEK293T Cells to Suspension Cell Culture in Chemically Defined Culture Medium
          High-Throughput Screening for High-Performance Cell Culture Media Development
          Scalable Bioprocessing Strategies for Intensified Viral Vector Production in HEK293 Cell Culture
          Novel Chemically Defined HEK293 Medium for High Cell Density Perfusion Viral Vector Production in scale-X Structured Fixed-bed Bioreactor
          Product Matrix
          Bioproduction Product Application Matrix
          Publications
          OPEN ACCESS: Chatel, Alex & Drugmand, Jean Christophe. (2023) AAV manufacturing: The benefits of growing serum-free, suspension HEK293 cells in the scale-X fixed-bed bioreactor. Univercells Technologies.
          OPEN ACCESS: Vaz, Tiago A. et al. (2023) Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures. Biotechnology Journal.
          OPEN ACCESS: Joe, Carina C. D. et al. (2021) Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs. Biotechnology and Bioengineering.
          OPEN ACCESS: Joe, Carina C. D. et al. (2023) Accelerated and intensified manufacturing of an adenovirus-vectored vaccine to enable rapid outbreak response. Biotechnology and Bioengineering.
          Schwarz, Hubert et al. (2019) Small-scale bioreactor supports high density HEK293 cell perfusion culture for the production of recombinant Erythropoietin. Journal of Biotechnology.
          View All Publications
          COA Search
          Certificate of Analysis Search
          © 2026 FUJIFILM Biosciences. All rights reserved.